Animal models for influenza viruses: Implications for universal vaccine development

Pathogens

Volumn 3, Issue 4, 2014, Pages 846-874

  Margine, Irina ^a   Krammer, Florian ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Heterosubtypic immunity; Influenza animal models; Influenza virus; Universal influenza virus vaccine

Indexed keywords

AMANTADINE; COMPLEMENT MEMBRANE ATTACK COMPLEX; FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OSELTAMIVIR; PERAMIVIR; RECOMBINANT VACCINE; RIMANTADINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN; VIRUS LIKE PARTICLE VACCINE; VIRUS SIALIDASE; ZANAMIVIR;

ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EXPERIMENTAL ANIMAL; IMMUNOGENICITY; IMMUNOLOGICAL TECHNIQUE; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INTERSTITIAL PNEUMONIA; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REVIEW; TRACHEOBRONCHITIS; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 85000542356     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens3040845     Document Type: Review

References (202)

1. Shaw, M.L.; Palese, P. Orthomyxoviridae: The viruses and their replication. In Fields Virology, 6th ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 1647–1689.
2. Tong, S.; Li, Y.; Rivailler, P.; Conrardy, C.; Castillo, D.A.; Chen, L.M.; Recuenco, S.; Ellison, J.A.; Davis, C.T.; York, I.A. et al. A distinct lineage of influenza a virus from bats. Proc. Natl. Acad. Sci. USA 2012, 109, 4269–4274.
3. Tong, S.; Zhu, X.; Li, Y.; Shi, M.; Zhang, J.; Bourgeois, M.; Yang, H.; Chen, X.; Recuenco, S.; Gomez, J. et al. New world bats harbor diverse influenza a viruses. PLoS Pathog 2013, 9, e1003657.
4. Cox, N.J.; Subbarao, K. Global epidemiology of influenza: Past and present. Annu. Rev. Med. 2000, 51, 407–421.
5. Bouvier, N.M.; Palese, P. The biology of influenza viruses. Vaccine 2008, 26, D49–D53.
6. Beigel, J.H.; Farrar, J.; Han, A.M.; Hayden, F.G.; Hyer, R.; de Jong, M.D.; Lochindarat, S.; Nguyen, T.K.; Nguyen, T.H.; Tran, T.H. et al. Avian influenza a (H5N1) infection in humans. N. Engl. J. Med. 2005, 353, 1374–1385.
7. Butt, K.M.; Smith, G.J.; Chen, H.; Zhang, L.J.; Leung, Y.H.; Xu, K.M.; Lim, W.; Webster, R.G.; Yuen, K.Y.; Peiris, J.S. et al. Human infection with an avian H9N2 influenza a virus in hong kong in 2003. J. Clin. Microbiol. 2005, 43, 5760–5767.
8. Aamir, U.B.; Naeem, K.; Ahmed, Z.; Obert, C.A.; Franks, J.; Krauss, S.; Seiler, P.; Webster, R.G. Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from pakistan. Virology 2009, 390, 212–220.
9. Munster, V.J.; de Wit, E.; van Riel, D.; Beyer, W.E.; Rimmelzwaan, G.F.; Osterhaus, A.D.; Kuiken, T.; Fouchier, R.A. The molecular basis of the pathogenicity of the dutch highly pathogenic human influenza a H7N7 viruses. J. Infect. Dis. 2007, 196, 258–265.
10. Wei, S.H.; Yang, J.R.; Wu, H.S.; Chang, M.C.; Lin, J.S.; Lin, C.Y.; Liu, Y.L.; Lo, Y.C.; Yang, C.H.; Chuang, J.H. et al. Human infection with avian influenza a h6n1 virus: An epidemiological analysis. Lancet Respir. Med. 2013, 1, 771–778.
11. Krammer, F.; Palese, P. Universal influenza virus vaccines: Need for clinical trials. Nature Immunol. 2013, 15, 3–5.
12. To, K.K.; Tsang, A.K.; Chan, J.F.; Cheng, V.C.; Chen, H.; Yuen, K.Y. Emergence in china of human disease due to avian influenza a(H10N8)—cause for concern? J. Infect. 2014, 68, 205–215.
13. Bouvier, N.M.; Lowen, A.C. Animal models for influenza virus pathogenesis and transmission. Viruses 2010, 2, 1530–1563
14. Connor, R.J.; Kawaoka, Y.; Webster, R.G.; Paulson, J.C. Receptor specificity in human, avian, and equine h2 and h3 influenza virus isolates. Virology 1994, 205, 17–23.
15. Baum, L.G.; Paulson, J.C. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem. Suppl. 1990, 40, 35–38.
16. Yu, H.; Gao, Z.; Feng, Z.; Shu, Y.; Xiang, N.; Zhou, L.; Huai, Y.; Feng, L.; Peng, Z.; Li, Z. et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza a (H5N1) virus infection in china. PLoS One 2008, 3, e2985.
17. Rimmelzwaan, G.F.; Kuiken, T.; van Amerongen, G.; Bestebroer, T.M.; Fouchier, R.A.; Osterhaus, A.D. A primate model to study the pathogenesis of influenza a (H5N1) virus infection. Avian Dis. 2003, 47, 931–933.
18. Cheung, C.Y.; Poon, L.L.; Lau, A.S.; Luk, W.; Lau, Y.L.; Shortridge, K.F.; Gordon, S.; Guan, Y.; Peiris, J.S. Induction of proinflammatory cytokines in human macrophages by influenza a (H5N1) viruses: A mechanism for the unusual severity of human disease? Lancet 2002, 360, 1831–1837.
19. Korteweg, C.; Gu, J. Pathology, molecular biology, and pathogenesis of avian influenza a (H5N1) infection in humans. Am. J. Pathol. 2008, 172, 1155–1170.
20. Palese, P. Influenza: Old and new threats. Nat. Med. 2004, 10, S82–S87.
21. WHO. Influenza (seasonal); Available online: http://www.who.int/mediacentre/factsheets/fs211/en (accessed on 10 October 2014).
22. Monto, A.S. Epidemiology and virology of influenza illness. Am. J. Manag. Care 2000, 6, S255–S264.
23. Tamerius, J.; Nelson, M.I.; Zhou, S.Z.; Viboud, C.; Miller, M.A.; Alonso, W.J. Global influenza seasonality: Reconciling patterns across temperate and tropical regions. Environ. Health Perspect. 2011, 119, 439–445.
24. Lowen, A.; Palese, P. Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contact: A hypothesis. PLoS Curr. 2009, 1, RRN1002.
25. Lowen, A.C.; Steel, J.; Mubareka, S.; Palese, P. High temperature (30 degrees c) blocks aerosol but not contact transmission of influenza virus. J. Virol. 2008, 82, 5650–5652.
26. Ison, M.G. Clinical use of approved influenza antivirals: Therapy and prophylaxis. Influ. Other Respir. Viruses 2013, 7, 7–13.
27. Kamali, A.; Holodniy, M. Influenza treatment and prophylaxis with neuraminidase inhibitors: A review. Infect. Drug Resist. 2013, 6, 187–198.
28. Hsu, J.; Santesso, N.; Mustafa, R.; Brozek, J.; Chen, Y.L.; Hopkins, J.P.; Cheung, A.; Hovhannisyan, G.; Ivanova, L.; Flottorp, S.A. et al. Antivirals for treatment of influenza: A systematic review and meta-analysis of observational studies. Ann. Intern. Med. 2012, 156, 512–524.
29. De Clercq, E. Antiviral agents active against influenza a viruses. Nat. Rev. Drug Discov. 2006, 5, 1015–1025.
30. Nichol, K.L. Efficacy and effectiveness of influenza vaccination. Vaccine 2008, 26, D17–D22.
31. Palese, P. Making better influenza virus vaccines? Emerg. Infect. Dis. 2006, 12, 61–65.
32. Barr, I.G.; Jelley, L.L. The coming era of quadrivalent human influenza vaccines: Who will benefit? Drugs 2012, 72, 2177–2185.
33. Ambrose, C.S.; Levin, M.J. The rationale for quadrivalent influenza vaccines. Hum. Vaccin. Immunother. 2012, 8, 81–88.
34. Wilde, J.A.; McMillan, J.A.; Serwint, J.; Butta, J.; O'Riordan, M.A.; Steinhoff, M.C. Effectiveness of influenza vaccine in health care professionals: A randomized trial. JAMA: J. Am. Med. Assoc. 1999, 281, 908–913.
35. Belshe, R.B.; Mendelman, P.M.; Treanor, J.; King, J.; Gruber, W.C.; Piedra, P.; Bernstein, D.I.; Hayden, F.G.; Kotloff, K.; Zangwill, K. et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N. Engl. J. Med. 1998, 338, 1405–1412.
36. Yohannes, K.; Roche, P.; Spencer, J.; Hampson, A. Annual report of the national influenza surveillance scheme, 2002. Commun. Dis. Intell. Q. Rep. 2003, 27, 162–172.
37. Bridges, C.B.; Thompson, W.W.; Meltzer, M.I.; Reeve, G.R.; Talamonti, W.J.; Cox, N.J.; Lilac, H.A.; Hall, H.; Klimov, A.; Fukuda, K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA: J. Am. Med. Assoc. 2000, 284, 1655–1663.
38. Borse, R.H.; Shrestha, S.S.; Fiore, A.E.; Atkins, C.Y.; Singleton, J.A.; Furlow, C.; Meltzer, M.I. Effects of vaccine program against pandemic influenza a (H1N1) virus, united states, 2009–2010. Emerg. Infect. Dis. 2013, 19, 439–448.
39. Pica, N.; Palese, P. Toward a universal influenza virus vaccine: Prospects and challenges. Annu. Rev. Med. 2013, 64, 189–202.
40. Krammer, F.; Palese, P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Current opinion in virology 2013, 3, 521–530.
41. Smith, W.; Manch, M.D.; Andrews, C.H.; Lond, M.D.; Laidlaw, P.P. A virus obtained from influenza patients. Lancet 1933, 222, 66–68.
42. The virus of influenza. Lancet 1933, 222, 83.
43. MacInnes, H.; Zhou, Y.; Gouveia, K.; Cromwell, J.; Lowery, K.; Layton, R.C.; Zubelewicz, M.; Sampath, R.; Hofstadler, S.; Liu, Y. et al. Transmission of aerosolized seasonal H1N1 influenza a to ferrets. PLoS One 2011, 6, e24448.
44. Kang, Y.M.; Song, B.M.; Lee, J.S.; Kim, H.S.; Seo, S.H. Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets. Arch. Virol. 2011, 156, 759–767.
45. Huang, S.S.; Banner, D.; Fang, Y.; Ng, D.C.; Kanagasabai, T.; Kelvin, D.J.; Kelvin, A.A. Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza b infections depict distinct clinical pictures in ferrets. PLoS One 2011, 6, e27512.
46. Meunier, I.; Embury-Hyatt, C.; Stebner, S.; Gray, M.; Bastien, N.; Li, Y.; Plummer, F.; Kobinger, G.P.; von Messling, V. Virulence differences of closely related pandemic 2009 H1N1 isolates correlate with increased inflammatory responses in ferrets. Virology 2012, 422, 125–131.
47. Van den Brand, J.M.; Stittelaar, K.J.; van Amerongen, G.; Reperant, L.; de Waal, L.; Osterhaus, A.D.; Kuiken, T. Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets. PLoS One 2012, 7, e42343.
48. Malakhov, M.P.; Aschenbrenner, L.M.; Smee, D.F.; Wandersee, M.K.; Sidwell, R.W.; Gubareva, L.V.; Mishin, V.P.; Hayden, F.G.; Kim, D.H.; Ing, A., et al. Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob. Agents Chemother. 2006, 50, 1470–1479.
49. Chen, G.L.; Lamirande, E.W.; Yang, C.F.; Jin, H.; Kemble, G.; Subbarao, K. Evaluation of replication and cross-reactive antibody responses of h2 subtype influenza viruses in mice and ferrets. J. Virol. 2010, 84, 7695–7702.
50. Lee, Y.N.; Lee, D.H.; Park, J.K.; Yuk, S.S.; Kwon, J.H.; Nahm, S.S.; Lee, J.B.; Park, S.Y.; Choi, I.S.; Song, C.S. Experimental infection and natural contact exposure of ferrets with canine influenza virus (H3N2). J. Gen. Virol. 2013, 94, 293–297.
51. Govorkova, E.A.; Rehg, J.E.; Krauss, S.; Yen, H.L.; Guan, Y.; Peiris, M.; Nguyen, T.D.; Hanh, T.H.; Puthavathana, P.; Long, H.T. et al. Lethality to ferrets of h5n1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 2005, 79, 2191–2198.
52. Xu, Q.; Chen, Z.; Cheng, X.; Xu, L.; Jin, H. Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus. PLoS One 2013, 8, e76884.
53. Kimble, J.B.; Sorrell, E.; Shao, H.; Martin, P.L.; Perez, D.R. Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc. Natl. Acad. Sci. USA 2011, 108, 12084–12088.
54. Belser, J.A.; Gustin, K.M.; Pearce, M.B.; Maines, T.R.; Zeng, H.; Pappas, C.; Sun, X.; Carney, P.J.; Villanueva, J.M.; Stevens, J.; et al. Pathogenesis and transmission of avian influenza a (H7N9) virus in ferrets and mice. Nature 2013, 501, 556–559.
55. Richard, M.; Schrauwen, E.J.; de Graaf, M.; Bestebroer, T.M.; Spronken, M.I.; van Boheemen, S.; de Meulder, D.; Lexmond, P.; Linster, M.; Herfst, S. et al. Limited airborne transmission of H7N9 influenza a virus between ferrets. Nature 2013, 501, 560–563.
56. Van Riel, D.; Munster, V.J.; de Wit, E.; Rimmelzwaan, G.F.; Fouchier, R.A.; Osterhaus, A.D.; Kuiken, T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 2007, 171, 1215–1223.
57. Stark, G.V.; Long, J.P.; Ortiz, D.I.; Gainey, M.; Carper, B.A.; Feng, J.; Miller, S.M.; Bigger, J.E.; Vela, E.M. Clinical profiles associated with influenza disease in the ferret model. PLoS One 2013, 8, e58337.
58. Huang, S.S.; Banner, D.; Degousee, N.; Leon, A.J.; Xu, L.; Paquette, S.G.; Kanagasabai, T.; Fang, Y.; Rubino, S.; Rubin, B. et al. Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. J. Virol. 2012, 86, 13187–13201.
59. Bodewes, R.; Kreijtz, J.H.; van Amerongen, G.; Fouchier, R.A.; Osterhaus, A.D.; Rimmelzwaan, G.F.; Kuiken, T. Pathogenesis of influenza a/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am. J. Pathol. 2011, 179, 30–36.
60. Bodewes, R.; Rimmelzwaan, G.F.; Osterhaus, A.D. Animal models for the preclinical evaluation of candidate influenza vaccines. Expert Rev. Vaccines 2010, 9, 59–72.
61. Zitzow, L.A.; Rowe, T.; Morken, T.; Shieh, W.J.; Zaki, S.; Katz, J.M. Pathogenesis of avian influenza a (H5N1) viruses in ferrets. J. Virol. 2002, 76, 4420–4429.
62. Van Riel, D.; Munster, V.J.; de Wit, E.; Rimmelzwaan, G.F.; Fouchier, R.A.; Osterhaus, A.D.; Kuiken, T. H5N1 virus attachment to lower respiratory tract. Science 2006, 312, 399.
63. Herlocher, M.L.; Truscon, R.; Elias, S.; Yen, H.L.; Roberts, N.A.; Ohmit, S.E.; Monto, A.S. Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets. J. Infect. Dis. 2004, 190, 1627–1630.
64. Maines, T.R.; Jayaraman, A.; Belser, J.A.; Wadford, D.A.; Pappas, C.; Zeng, H.; Gustin, K.M.; Pearce, M.B.; Viswanathan, K.; Shriver, Z.H. et al. Transmission and pathogenesis of swine-origin 2009 a (H1N1) influenza viruses in ferrets and mice. Science 2009, 325, 484–487.
65. Staeheli, P.; Grob, R.; Meier, E.; Sutcliffe, J.G.; Haller, O. Influenza virus-susceptible mice carry mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 1988, 8, 4518–4523.
66. Grimm, D.; Staeheli, P.; Hufbauer, M.; Koerner, I.; Martinez-Sobrido, L.; Solorzano, A.; Garcia-Sastre, A.; Haller, O.; Kochs, G. Replication fitness determines high virulence of influenza a virus in mice carrying functional mx1 resistance gene. Proc. Natl. Acad. Sci. USA 2007, 104, 6806–6811.
67. Narasaraju, T.; Sim, M.K.; Ng, H.H.; Phoon, M.C.; Shanker, N.; Lal, S.K.; Chow, V.T. Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: Insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect./Inst. Pasteur 2009, 11, 2–11.
68. Sakabe, S.; Ozawa, M.; Takano, R.; Iwastuki-Horimoto, K.; Kawaoka, Y. Mutations in pa, np, and ha of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. Virus Res. 2011, 158, 124–129.
69. Liu, Q.; Chen, H.; Huang, J.; Chen, Y.; Gu, M.; Wang, X.; Hu, S.; Liu, X.; Liu, X. A nonpathogenic duck-origin H9N2 influenza a virus adapts to high pathogenicity in mice. Arch. Virol. 2014, doi:10.1007/s00705-014-2062-y.
70. Medina, R.A.; Manicassamy, B.; Stertz, S.; Seibert, C.W.; Hai, R.; Belshe, R.B.; Frey, S.E.; Basler, C.F.; Palese, P.; Garcia-Sastre, A. Pandemic 2009 H1N1 vaccine protects against 1918 spanish influenza virus. Nat. Commun. 2010, 1, 28.
71. Gao, P.; Watanabe, S.; Ito, T.; Goto, H.; Wells, K.; McGregor, M.; Cooley, A.J.; Kawaoka, Y. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza a virus isolates from humans in hong kong. J. Virol. 1999, 73, 3184–3189.
72. Lu, X.; Tumpey, T.M.; Morken, T.; Zaki, S.R.; Cox, N.J.; Katz, J.M. A mouse model for the evaluation of pathogenesis and immunity to influenza a (H5N1) viruses isolated from humans. J. Virol. 1999, 73, 5903–5911.
73. Xu, L.; Bao, L.; Deng, W.; Zhu, H.; Chen, T.; Lv, Q.; Li, F.; Yuan, J.; Xiang, Z.; Gao, K. et al. The mouse and ferret models for studying the novel avian-origin human influenza a (H7N9) virus. Virol. J. 2013, 10, 253.
74. Ibricevic, A.; Pekosz, A.; Walter, M.J.; Newby, C.; Battaile, J.T.; Brown, E.G.; Holtzman, M.J.; Brody, S.L. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 2006, 80, 7469–7480.
75. Carey, M.A.; Bradbury, J.A.; Rebolloso, Y.D.; Graves, J.P.; Zeldin, D.C.; Germolec, D.R. Pharmacologic inhibition of cox-1 and cox-2 in influenza a viral infection in mice. PLoS One 2010, 5, e11610.
76. Van Riel, D.; Munster, V.J.; de Wit, E.; Rimmelzwaan, G.F.; Fouchier, R.A.; Osterhaus, A.D.; Kuiken, T. H5N1 virus attachment to lower respiratory tract. Science 2006, 312, 399.
77. Herlocher, M.L.; Truscon, R.; Elias, S.; Yen, H.L.; Roberts, N.A.; Ohmit, S.E.; Monto, A.S. Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets. J. Infect. Dis. 2004, 190, 1627–1630.
78. Maines, T.R.; Jayaraman, A.; Belser, J.A.; Wadford, D.A.; Pappas, C.; Zeng, H.; Gustin, K.M.; Pearce, M.B.; Viswanathan, K.; Shriver, Z.H. et al. Transmission and pathogenesis of swine-origin 2009 a (H1N1) influenza viruses in ferrets and mice. Science 2009, 325, 484–487.
79. Staeheli, P.; Grob, R.; Meier, E.; Sutcliffe, J.G.; Haller, O. Influenza virus-susceptible mice carry mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 1988, 8, 4518–4523.
80. Grimm, D.; Staeheli, P.; Hufbauer, M.; Koerner, I.; Martinez-Sobrido, L.; Solorzano, A.; Garcia-Sastre, A.; Haller, O.; Kochs, G. Replication fitness determines high virulence of influenza a virus in mice carrying functional mx1 resistance gene. Proc. Natl. Acad. Sci. USA 2007, 104, 6806–6811.
81. Narasaraju, T.; Sim, M.K.; Ng, H.H.; Phoon, M.C.; Shanker, N.; Lal, S.K.; Chow, V.T. Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: Insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect./Inst. Pasteur 2009, 11, 2–11.
82. Sakabe, S.; Ozawa, M.; Takano, R.; Iwastuki-Horimoto, K.; Kawaoka, Y. Mutations in pa, np, and ha of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. Virus Res. 2011, 158, 124–129.
83. Liu, Q.; Chen, H.; Huang, J.; Chen, Y.; Gu, M.; Wang, X.; Hu, S.; Liu, X.; Liu, X. A nonpathogenic duck-origin H9N2 influenza a virus adapts to high pathogenicity in mice. Arch. Virol. 2014, doi:10.1007/s00705-014-2062-y.
84. Medina, R.A.; Manicassamy, B.; Stertz, S.; Seibert, C.W.; Hai, R.; Belshe, R.B.; Frey, S.E.; Basler, C.F.; Palese, P.; Garcia-Sastre, A. Pandemic 2009 H1N1 vaccine protects against 1918 spanish influenza virus. Nat. Commun. 2010, 1, 28.
85. Gao, P.; Watanabe, S.; Ito, T.; Goto, H.; Wells, K.; McGregor, M.; Cooley, A.J.; Kawaoka, Y. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza a virus isolates from humans in hong kong. J. Virol. 1999, 73, 3184–3189.
86. Lu, X.; Tumpey, T.M.; Morken, T.; Zaki, S.R.; Cox, N.J.; Katz, J.M. A mouse model for the evaluation of pathogenesis and immunity to influenza a (H5N1) viruses isolated from humans. J. Virol. 1999, 73, 5903–5911.
87. Xu, L.; Bao, L.; Deng, W.; Zhu, H.; Chen, T.; Lv, Q.; Li, F.; Yuan, J.; Xiang, Z.; Gao, K. et al. The mouse and ferret models for studying the novel avian-origin human influenza a (H7N9) virus. Virol. J. 2013, 10, 253.
88. Ibricevic, A.; Pekosz, A.; Walter, M.J.; Newby, C.; Battaile, J.T.; Brown, E.G.; Holtzman, M.J.; Brody, S.L. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 2006, 80, 7469–7480.
89. Carey, M.A.; Bradbury, J.A.; Rebolloso, Y.D.; Graves, J.P.; Zeldin, D.C.; Germolec, D.R. Pharmacologic inhibition of cox-1 and cox-2 in influenza a viral infection in mice. PLoS One 2010, 5, e11610.
90. DiLillo, D.J.; Tan, G.S.; Palese, P.; Ravetch, J.V. Broadly neutralizing hemagglutinin stalk-specific antibodies require fcgammar interactions for protection against influenza virus in vivo. Nat. Med. 2014, 20, 143–151.
91. Matsuoka, Y.; Lamirande, E.W.; Subbarao, K. The mouse model for influenza. Curr. Protoc. Microbiol. 2009, Chapter 15, Unit 15G 13, doi:10.1002/9780471729259.mc15g03s13.
92. Ma, W.; Lager, K.M.; Vincent, A.L.; Janke, B.H.; Gramer, M.R.; Richt, J.A. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 2009, 56, 326–337.
93. Ito, T.; Couceiro, J.N.; Kelm, S.; Baum, L.G.; Krauss, S.; Castrucci, M.R.; Donatelli, I.; Kida, H.; Paulson, J.C.; Webster, R.G. et al. Molecular basis for the generation in pigs of influenza a viruses with pandemic potential. J. Virol. 1998, 72, 7367–7373.
94. Barnard, D.L. Animal models for the study of influenza pathogenesis and therapy. Antivir. Res. 2009, 82, A110–A122.
95. Lipatov, A.S.; Kwon, Y.K.; Sarmento, L.V.; Lager, K.M.; Spackman, E.; Suarez, D.L.; Swayne, D.E. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog. 2008, 4, e1000102.
96. Dea, S.; Bilodeau, R.; Sauvageau, R.; Montpetit, C.; Martineau, G.P. Antigenic variant of swine influenza virus causing proliferative and necrotizing pneumonia in pigs. J. Vet. Diagn. Invest.: Off. Publ. Am. Assoc. Vet. Lab. Diagnosticians, Inc 1992, 4, 380–392.
97. Chen, Q.; Madson, D.; Miller, C.L.; Harris, D.L. Vaccine development for protecting swine against influenza virus. Anim. Health Res. Rev./Conf. Res. Workers Anim. Dis. 2012, 13, 181–195.
98. Karlsson, E.A.; Engel, G.A.; Feeroz, M.M.; San, S.; Rompis, A.; Lee, B.P.; Shaw, E.; Oh, G.; Schillaci, M.A.; Grant, R. et al. Influenza virus infection in nonhuman primates. Emerg. Infect. Dis. 2012, 18, 1672–1675.
99. Carroll, T.D.; Matzinger, S.R.; Genesca, M.; Fritts, L.; Colon, R.; McChesney, M.B.; Miller, C.J. Interferon-induced expression of mxa in the respiratory tract of rhesus macaques is suppressed by influenza virus replication. J. Immunol. 2008, 180, 2385–2395.
100. Rimmelzwaan, G.F.; Baars, M.; van Amerongen, G.; van Beek, R.; Osterhaus, A.D. A single dose of an iscom influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect cynomolgus macaques against distant drift variants of influenza a (H3N2) viruses. Vaccine 2001, 20, 158–163.
101. Safronetz, D.; Rockx, B.; Feldmann, F.; Belisle, S.E.; Palermo, R.E.; Brining, D.; Gardner, D.; Proll, S.C.; Marzi, A.; Tsuda, Y. et al. Pandemic swine-origin H1N1 influenza a virus isolates show heterogeneous virulence in macaques. J. Virol. 2011, 85, 1214–1223.
102. Baskin, C.R.; Bielefeldt-Ohmann, H.; Tumpey, T.M.; Sabourin, P.J.; Long, J.P.; Garcia-Sastre, A.; Tolnay, A.E.; Albrecht, R.; Pyles, J.A.; Olson, P.H. et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 2009, 106, 3455–3460.
103. Watanabe, T.; Kiso, M.; Fukuyama, S.; Nakajima, N.; Imai, M.; Yamada, S.; Murakami, S.; Yamayoshi, S.; Iwatsuki-Horimoto, K.; Sakoda, Y. et al. Characterization of H7N9 influenza a viruses isolated from humans. Nature 2013, 501, 551–555
104. Rimmelzwaan, G.F.; Baars, M.; van Beek, R.; van Amerongen, G.; Lovgren-Bengtsson, K.; Claas, E.C.; Osterhaus, A.D. Induction of protective immunity against influenza virus in a macaque model: Comparison of conventional and iscom vaccines. J. Gen. Virol. 1997, 78, 757–765.
105. Cilloniz, C.; Shinya, K.; Peng, X.; Korth, M.J.; Proll, S.C.; Aicher, L.D.; Carter, V.S.; Chang, J.H.; Kobasa, D.; Feldmann, F. et al. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 2009, 5, e1000604.
106. Lowen, A.C.; Mubareka, S.; Tumpey, T.M.; García-Sastre, A.; Palese, P. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. USA 2006, 103, 9988–9992.
107. Lowen, A.C.; Mubareka, S.; Steel, J.; Palese, P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007, 3, 1470–1476.
108. Mubareka, S.; Lowen, A.C.; Steel, J.; Coates, A.L.; Garcia-Sastre, A.; Palese, P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J. Infect. Dis. 2009, 199, 858–865.
109. Pica, N.; Chou, Y.Y.; Bouvier, N.M.; Palese, P. Transmission of influenza b viruses in the guinea pig. J. Virol. 2012, 86, 4279–4287.
110. Lowen, A.C.; Steel, J.; Mubareka, S.; Carnero, E.; García-Sastre, A.; Palese, P. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J. Virol. 2009, 83, 2803–2818.
111. Seibert, C.W.; Rahmat, S.; Krause, J.C.; Eggink, D.; Albrecht, R.A.; Goff, P.H.; Krammer, F.; Duty, J.A.; Bouvier, N.M.; García-Sastre, A. et al. Recombinant iga is sufficient to prevent influenza virus transmission in guinea pigs. J. Virol. 2013, 87, 7793–7804.
112. Daly, J.M.; Yates, R.J.; Browse, G.; Swann, Z.; Newton, J.R.; Jessett, D.; Davis-Poynter, N.; Mumford, J.A. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet. J. 2003, 35, 458–462.
113. Abou-Donia, H.; Jennings, R.; Potter, C.W. Growth of influenza a viruses in hamsters. Arch. Virol. 1980, 65, 99–107.
114. Jennings, R.; Potter, C.W. The hamster as a model for the study of immunity to influenza virus infection. Fed. Proc. 1978, 37, 2072–2073.
115. Potter, C.W.; Jennings, R. The hamster as a model system for the study of influenza vaccines. Postgrad. Med. J. 1976, 52, 345–351.
116. Jennings, R.; Denton, M.D.; Potter, C.W. The hamster as an experimental animal for the study of influenza. I. The role of antibody in protection. Med. Microbiol. Immunol. 1976, 162, 217–226.
117. Jennings, R.; Phair, J.P.; Denton, M.D.; Potter, C.W. The hamster as an experimental animal for the study of influenza. Ii. The role of spleen cells in protection. Med. Microbiol. Immunol. 1976, 162, 227–237.
118. Shinya, K.; Makino, A.; Tanaka, H.; Hatta, M.; Watanabe, T.; Le, M.Q.; Imai, H.; Kawaoka, Y. Systemic dissemination of H5N1 influenza a viruses in ferrets and hamsters after direct intragastric inoculation. J. Virol. 2011, 85, 4673–4678.
119. Ali, M.J.; Teh, C.Z.; Jennings, R.; Potter, C.W. Transmissibility of influenza viruses in hamsters. Arch. Virol. 1982, 72, 187–197.
120. Eichelberger, M.C. The cotton rat as a model to study influenza pathogenesis and immunity. Viral. Immunol. 2007, 20, 243–249.
121. Boukhvalova, M.S.; Prince, G.A.; Blanco, J.C. The cotton rat model of respiratory viral infections. Biologicals 2009, 37, 152–159.
122. Yim, K.; Miles, B.; Zinsou, R.; Prince, G.; Boukhvalova, M. Efficacy of trivalent inactivated influenza vaccines in the cotton rat sigmodon hispidus model. Vaccine 2012, 30, 1291–1296.
123. Straight, T.M.; Ottolini, M.G.; Prince, G.A.; Eichelberger, M.C. Evidence of a cross-protective immune response to influenza a in the cotton rat model. Vaccine 2006, 24, 6264–6271.
124. Blanco, J.C.; Pletneva, L.M.; Wan, H.; Araya, Y.; Angel, M.; Oue, R.O.; Sutton, T.C.; Perez, D.R. Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains. J. Virol. 2013, 87, 2036–2045.
125. Swayne, D.E.; Suarez, D.L.; Schultz-Cherry, S.; Tumpey, T.M.; King, D.J.; Nakaya, T.; Palese, P.; Garcia-Sastre, A. Recombinant paramyxovirus type 1-avian influenza-h7 virus as a vaccine for protection of chickens against influenza and newcastle disease. Avian Dis. 2003, 47, 1047–1050.
126. Cornelissen, L.A.; de Vries, R.P.; de Boer-Luijtze, E.A.; Rigter, A.; Rottier, P.J.; de Haan, C.A. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 2010, 5, e10645.
127. Suarez, D.L.; Schultz-Cherry, S. Immunology of avian influenza virus: A review. Dev. Comp. Immunol. 2000, 24, 269–283.
128. Pantin-Jackwood, M.J.; Suarez, D.L. Vaccination of domestic ducks against H5N1 hpai: A review. Virus Res. 2013, 178, 21–34.
129. Chambers, T.M.; Quinlivan, M.; Sturgill, T.; Cullinane, A.; Horohov, D.W.; Zamarin, D.; Arkins, S.; Garcia-Sastre, A.; Palese, P. Influenza a viruses with truncated ns1 as modified live virus vaccines: Pilot studies of safety and efficacy in horses. Equine Vet. J. 2009, 41, 87–92.
130. Paillot, R.; Hannant, D.; Kydd, J.H.; Daly, J.M. Vaccination against equine influenza: Quid novi? Vaccine 2006, 24, 4047–4061.
131. Lee, D.H.; Bae, S.W.; Park, J.K.; Kwon, J.H.; Yuk, S.S.; Song, J.M.; Kang, S.M.; Kwon, Y.K.; Kim, H.Y.; Song, C.S. Virus-like particle vaccine protects against H3N2 canine influenza virus in dog. Vaccine 2013, 31, 3268–3273.
132. Van der Laan, J.W.; Herberts, C.; Lambkin-Williams, R.; Boyers, A.; Mann, A.J.; Oxford, J. Animal models in influenza vaccine testing. Expert Rev. Vaccines 2008, 7, 783–793.
133. Eichelberger, M.C.; Green, M.D. Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines. Expert Opin. Drug Metab. Toxicol. 2011, 7, 1117–1127.
134. Thangavel, R.R.; Bouvier, N.M. Animal models for influenza virus pathogenesis, transmission, and immunology. J. Immunol. Methods 2014, doi:10.1016/j.jim.2014.03.023.
135. Watanabe, H.; Numata, K.; Ito, T.; Takagi, K.; Matsukawa, A. Innate immune response in th1- and th2-dominant mouse strains. Shock 2004, 22, 460–466.
136. Pica, N.; Iyer, A.; Ramos, I.; Bouvier, N.M.; Fernandez-Sesma, A.; Garcia-Sastre, A.; Lowen, A.C.; Palese, P.; Steel, J. The dba.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza a and b viruses. J. Virol. 2011, 85, 12825–12829.
137. Okuno, Y.; Isegawa, Y.; Sasao, F.; Ueda, S. A common neutralizing epitope conserved between the hemagglutinins of influenza a virus h1 and h2 strains. J. Virol. 1993, 67, 2552–2558.
138. Tan, G.S.; Krammer, F.; Eggink, D.; Kongchanagul, A.; Moran, T.M.; Palese, P. A pan-h1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J. Virol. 2012, 86, 6179–6188.
139. Wang, T.T.; Tan, G.S.; Hai, R.; Pica, N.; Petersen, E.; Moran, T.M.; Palese, P. Broadly protective monoclonal antibodies against h3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog. 2010, 6, e1000796.
140. Wei, C.J.; Boyington, J.C.; McTamney, P.M.; Kong, W.P.; Pearce, M.B.; Xu, L.; Andersen, H.; Rao, S.; Tumpey, T.M.; Yang, Z.Y. et al. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010, 329, 1060–1064.
141. Pica, N.; Hai, R.; Krammer, F.; Wang, T.T.; Maamary, J.; Eggink, D.; Tan, G.S.; Krause, J.C.; Moran, T.; Stein, C.R. et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc. Natl. Acad. Sci. USA 2012, 109, 2573–2578.
142. Krammer, F.; Pica, N.; Hai, R.; Tan, G.S.; Palese, P. Hemagglutinin stalk-reactive antibodies are boosted following sequential infection with seasonal and pandemic H1N1 influenza virus in mice. J. Virol. 2012, 86, 10302–10307.
143. Wrammert, J.; Koutsonanos, D.; Li, G.M.; Edupuganti, S.; Sui, J.; Morrissey, M.; McCausland, M.; Skountzou, I.; Hornig, M.; Lipkin, W.I. et al. Broadly cross-reactive antibodies dominate the human b cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011, 208, 181–193.
144. Margine, I.; Hai, R.; Albrecht, R.A.; Obermoser, G.; Harrod, A.C.; Banchereau, J.; Palucka, K.; Garcia-Sastre, A.; Palese, P.; Treanor, J.J. et al. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J. Virol. 2013, 87, 4728–4737.
145. Steel, J.; Lowen, A.C.; Wang, T.T.; Yondola, M.; Gao, Q.; Haye, K.; Garcia-Sastre, A.; Palese, P. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. mBio 2010, doi:10.1128/mBio.00018-10.
146. Wei, C.J.; Yassine, H.M.; McTamney, P.M.; Gall, J.G.; Whittle, J.R.; Boyington, J.C.; Nabel, G.J. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure. Sci. Transl. Med. 2012, 4, 147ra114.
147. Kanekiyo, M.; Wei, C.J.; Yassine, H.M.; McTamney, P.M.; Boyington, J.C.; Whittle, J.R.; Rao, S.S.; Kong, W.P.; Wang, L.; Nabel, G.J. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 2013, 499, 102–106.
148. Krammer, F.; Margine, I.; Hai, R.; Flood, A.; Hirsh, A.; Tsvetnitsky, V.; Chen, D.; Palese, P. H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J. Virol. 2014, 88, 2340–2343.
149. Krammer, F.; Pica, N.; Hai, R.; Margine, I.; Palese, P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J. Virol. 2013, 87, 6542–6550.
150. Margine, I.; Krammer, F.; Hai, R.; Heaton, N.S.; Tan, G.S.; Andrews, S.A.; Runstadler, J.A.; Wilson, P.C.; Albrecht, R.A.; Garcia-Sastre, A. et al. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza a viruses. J. Virol. 2013, 87, 10435–10446.
151. Ekiert, D.C.; Bhabha, G.; Elsliger, M.A.; Friesen, R.H.; Jongeneelen, M.; Throsby, M.; Goudsmit, J.; Wilson, I.A. Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324, 246–251.
152. Terajima, M.; Cruz, J.; Co, M.D.; Lee, J.H.; Kaur, K.; Wrammert, J.; Wilson, P.C.; Ennis, F.A. Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies. J. Virol. 2011, 85, 13463–13467.
153. Lawrenz, M.B.; Wooten, R.M.; Zachary, J.F.; Drouin, S.M.; Weis, J.J.; Wetsel, R.A.; Norris, S.J. Effect of complement component C3 deficiency on experimental lyme borreliosis in mice. Infect. Immun. 2003, 71, 4432–4440.
154. Francis, T.; Magill, T.P. Immunological studies with the virus of influenza. J. Exp. Med. 1935, 62, 505–516.
155. Francis, T.; Shope, R.E. Neutralization tests with sera of convalescent or immunized animals and the viruses of swine and human influenza. J. Exp. Med. 1936, 63, 645–653.
156. Cameron, C.M.; Cameron, M.J.; Bermejo-Martin, J.F.; Ran, L.; Xu, L.; Turner, P.V.; Ran, R.; Danesh, A.; Fang, Y.; Chan, P.K. et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J. Virol. 2008, 82, 11308–11317.
157. Ochi, A.; Danesh, A.; Seneviratne, C.; Banner, D.; Devries, M.E.; Rowe, T.; Xu, L.; Ran, L.; Czub, M.; Bosinger, S.E. et al. Cloning, expression and immunoassay detection of ferret ifn-gamma. Dev. Comp. Immunol. 2008, 32, 890–897.
158. Nakata, M.; Itou, T.; Sakai, T. Molecular cloning and phylogenetic analysis of inflammatory cytokines of the ferret (mustela putorius furo). J. Vet. Med. Sci./ Jpn. Soc. Vet. Sci. 2008, 70, 543–550.
159. Rutigliano, J.A.; Doherty, P.C.; Franks, J.; Morris, M.Y.; Reynolds, C.; Thomas, P.G. Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection. J. Immunol. Methods 2008, 336, 71–77.
160. Park, S.J.; Kim, E.H.; Pascua, P.N.; Kwon, H.I.; Lim, G.J.; Decano, A.; Kim, S.M.; Song, M.K.; Shin, E.C.; Choi, Y.K. Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza a virus or trivalent inactivated vaccine immunization in ferret models. J. Gen. Virol. 2014, 95, 793–798.
161. O'Donnell, C.D.; Wright, A.; Vogel, L.; Boonnak, K.; Treanor, J.J.; Subbarao, K. Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 virus. Clin. Vaccine Immunol.: CVI 2014, doi:10.1128/CVI.00790-13.
162. Houser, K.V.; Pearce, M.B.; Katz, J.M.; Tumpey, T.M. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza a(H3N2)v virus in ferrets. J. Virol. 2013, 87, 13480–13489.
163. Krammer, F.; Hai, R.; Yondola, M.; Tan, G.S.; Leyva-Grado, V.H.; Ryder, A.B.; Miller, M.S.; Rose, J.K.; Palese, P.; Garcia-Sastre, A. et al. Assessment of influenza virus hemagglutinin stalkbased immunity in ferrets. J. Virol. 2014, 88, 3432–3442.
164. Chen, J.R.; Yu, Y.H.; Tseng, Y.C.; Chiang, W.L.; Chiang, M.F.; Ko, Y.A.; Chiu, Y.K.; Ma, H.H.; Wu, C.Y.; Jan, J.T. et al. Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections. Proc. Natl. Acad. Sci. USA 2014, 111, 2476–2481.
165. Leroux-Roels, I.; Borkowski, A.; Vanwolleghem, T.; Drame, M.; Clement, F.; Hons, E.; Devaster, J.M.; Leroux-Roels, G. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial. Lancet 2007, 370, 580–589.
166. Pearce, M.B.; Belser, J.A.; Gustin, K.M.; Pappas, C.; Houser, K.V.; Sun, X.; Maines, T.R.; Pantin- Jackwood, M.J.; Katz, J.M.; Tumpey, T.M. Seasonal trivalent inactivated influenza vaccine protects against 1918 spanish influenza virus infection in ferrets. J. Virol. 2012, 86, 7118–7125.
167. Chen, Z.; Baz, M.; Lu, J.; Paskel, M.; Santos, C.; Subbarao, K.; Jin, H.; Matsuoka, Y. Development of a high yield live attenuated H7N9 influenza vaccine that provides protection against homologous and heterologous h7 wild-type viruses in ferrets. J. Virol. 2014, doi:10.1128/JVI.00100-14.
168. Chen, G.L.; Lamirande, E.W.; Cheng, X.; Torres-Velez, F.; Orandle, M.; Jin, H.; Kemble, G.; Subbarao, K. Evaluation of three live attenuated h2 pandemic influenza vaccine candidates in mice and ferrets. J. Virol. 2014, 88, 2867–2876.
169. Suguitan, A.L., Jr.; McAuliffe, J.; Mills, K.L.; Jin, H.; Duke, G.; Lu, B.; Luke, C.J.; Murphy, B.; Swayne, D.E.; Kemble, G. et al. Live, attenuated influenza a H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med. 2006, 3, e360.
170. Talaat, K.R.; Karron, R.A.; Luke, C.J.; Thumar, B.; McMahon, B.A.; Chen, G.L.; Lamirande, E.W.; Jin, H.; Coelingh, K.L.; Kemble, G. et al. An open label phase i trial of a live attenuated h6n1 influenza virus vaccine in healthy adults. Vaccine 2011, 29, 3144–3148.
171. Talaat, K.R.; Karron, R.A.; Liang, P.H.; McMahon, B.A.; Luke, C.J.; Thumar, B.; Chen, G.L.; Min, J.Y.; Lamirande, E.W.; Jin, H. et al. An open-label phase i trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza Other Respir Viruses 2013, 7, 66–73.
172. Karron, R.A.; Talaat, K.; Luke, C.; Callahan, K.; Thumar, B.; Dilorenzo, S.; McAuliffe, J.; Schappell, E.; Suguitan, A.; Mills, K. et al. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 2009, 27, 4953–4960.
173. Matsuoka, Y.; Suguitan, A.; Orandle, M.; Paskel, M.; Boonnak, K.; Gardner, D.J.; Feldmann, F.; Feldmann, H.; Marino, M.; Jin, H. et al. African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates. J. Virol. 2014, 88, 8139–8152.
174. Richt, J.A.; Lekcharoensuk, P.; Lager, K.M.; Vincent, A.L.; Loiacono, C.M.; Janke, B.H.; Wu, W.H.; Yoon, K.J.; Webby, R.J.; Solorzano, A. et al. Vaccination of pigs against swine influenza viruses by using an ns1-truncated modified live-virus vaccine. J. Virol. 2006, 80, 11009–11018.
175. Wesley, R.D.; Tang, M.; Lager, K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 2004, 22, 3427–3434.
176. Masic, A.; Pyo, H.M.; Babiuk, S.; Zhou, Y. An eight-segment swine influenza virus harboring h1 and h3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs. J. Virol. 2013, 87, 10114–10125.
177. Hancock, K.; Veguilla, V.; Lu, X.; Zhong, W.; Butler, E.N.; Sun, H.; Liu, F.; Dong, L.; DeVos, J.R.; Gargiullo, P.M. et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 2009, 361, 1945–1952.
178. Van den Brand, J.M.; Kreijtz, J.H.; Bodewes, R.; Stittelaar, K.J.; van Amerongen, G.; Kuiken, T.; Simon, J.; Fouchier, R.A.; Del Giudice, G.; Rappuoli, R. et al. Efficacy of vaccination with different combinations of mf59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets. J. Virol. 2011, 85, 2851–2858.
179. Ellebedy, A.H.; Ducatez, M.F.; Duan, S.; Stigger-Rosser, E.; Rubrum, A.M.; Govorkova, E.A.; Webster, R.G.; Webby, R.J. Impact of prior seasonal influenza vaccination and infection on pandemic a (H1N1) influenza virus replication in ferrets. Vaccine 2011, 29, 3335–3339.
180. Chen, G.L.; Min, J.Y.; Lamirande, E.W.; Santos, C.; Jin, H.; Kemble, G.; Subbarao, K. Comparison of a live attenuated 2009 h1n1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets. J. Infect. Dis. 2011, 203, 930–936.
181. Vincent, A.L.; Lager, K.M.; Janke, B.H.; Gramer, M.R.; Richt, J.A. Failure of protection and enhanced pneumonia with a us H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet. Microbiol. 2008, 126, 310–323.
182. Reeth, K.V.; Brown, I.; Essen, S.; Pensaert, M. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza a virus subtypes endemic in european pigs. Virus Res. 2004, 103, 115–124.
183. Macklin, M.D.; McCabe, D.; McGregor, M.W.; Neumann, V.; Meyer, T.; Callan, R.; Hinshaw, V.S.; Swain, W.F. Immunization of pigs with a particle-mediated dna vaccine to influenza a virus protects against challenge with homologous virus. J. Virol. 1998, 72, 1491–1496.
184. Gauger, P.C.; Vincent, A.L.; Loving, C.L.; Henningson, J.N.; Lager, K.M.; Janke, B.H.; Kehrli, M.E., Jr.; Roth, J.A. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) a/H1N1 influenza virus. Vet. Pathol. 2012, 49, 900–912.
185. Gauger, P.C.; Vincent, A.L.; Loving, C.L.; Lager, K.M.; Janke, B.H.; Kehrli, M.E., Jr.; Roth, J.A. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 2011, 29, 2712–2719.
186. Kyriakis, C.S.; Gramer, M.R.; Barbe, F.; van Doorsselaere, J.; van Reeth, K. Efficacy of commercial swine influenza vaccines against challenge with a recent european H1N1 field isolate. Vet. Microbiol. 2010, 144, 67–74.
187. Van Reeth, K.; Labarque, G.; de Clercq, S.; Pensaert, M. Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. Vaccine 2001, 19, 4479–4486.
188. Van Reeth, K.; Van Gucht, S.; Pensaert, M. Investigations of the efficacy of european H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype. Vet. Rec. 2003, 153, 9–0
189. Vincent, A.L.; Ma, W.; Lager, K.M.; Richt, J.A.; Janke, B.H.; Sandbulte, M.R.; Gauger, P.C.; Loving, C.L.; Webby, R.J.; Garcia-Sastre, A. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccineassociated enhanced respiratory disease. J. Virol. 2012, 86, 10597–10605.
190. Braucher, D.R.; Henningson, J.N.; Loving, C.L.; Vincent, A.L.; Kim, E.; Steitz, J.; Gambotto, A.A.; Kehrli, M.E., Jr. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs. Clin. Vaccine Immunol.: CVI 2012, 19, 1722–1729.
191. De Vleeschauwer, A.R.; Baras, B.; Kyriakis, C.S.; Jacob, V.; Planty, C.; Giannini, S.L.; Mossman, S.; van Reeth, K. Efficacy of an as03a-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs. Vaccine 2012, 30, 5557–5563.
192. Khurana, S.; Loving, C.L.; Manischewitz, J.; King, L.R.; Gauger, P.C.; Henningson, J.; Vincent, A.L.; Golding, H. Vaccine-induced anti-ha2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Sci. Transl. Med. 2013, 5, 200ra114.
193. Corti, D.; Voss, J.; Gamblin, S.J.; Codoni, G.; Macagno, A.; Jarrossay, D.; Vachieri, S.G.; Pinna, D.; Minola, A.; Vanzetta, F. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza a hemagglutinins. Science 2011, 333, 850–856.
194. Janjua, N.Z.; Skowronski, D.M.; Hottes, T.S.; Osei, W.; Adams, E.; Petric, M.; Sabaiduc, S.; Chan, T.; Mak, A.; Lem, M. et al. Seasonal influenza vaccine and increased risk of pandemic a/h1n1- related illness: First detection of the association in british columbia, canada. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 2010, 51, 1017–1027.
195. Skowronski, D.M.; de Serres, G.; Crowcroft, N.S.; Janjua, N.Z.; Boulianne, N.; Hottes, T.S.; Rosella, L.C.; Dickinson, J.A.; Gilca, R.; Sethi, P. et al. Association between the 2008–09 seasonal influenza vaccine and pandemic h1n1 illness during spring-summer 2009: Four observational studies from canada. PLoS Med. 2010, 7, e1000258.
196. Cowling, B.J.; Ng, S.; Ma, E.S.; Fang, V.J.; So, H.C.; Wai, W.; Cheng, C.K.; Wong, J.Y.; Chan, K.H.; Ip, D.K. et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: A randomized controlled trial. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 2012, 55, 695–702.
197. Garcia-Garcia, L.; Valdespino-Gomez, J.L.; Lazcano-Ponce, E.; Jimenez-Corona, A.; Higuera-Iglesias, A.; Cruz-Hervert, P.; Cano-Arellano, B.; Garcia-Anaya, A.; Ferreira-Guerrero, E.; Baez-Saldana, R. et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza a/H1N1 2009: Case-control study in mexico city. BMJ 2009, 339, b3928.
198. Johns, M.C.; Eick, A.A.; Blazes, D.L.; Lee, S.E.; Perdue, C.L.; Lipnick, R.; Vest, K.G.; Russell, K.L.; DeFraites, R.F.; Sanchez, J.L. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among us military personnel. PLoS One 2010, 5, e10722.
199. Heinen, P.P.; Rijsewijk, F.A.; de Boer-Luijtze, E.A.; Bianchi, A.T. Vaccination of pigs with a dna construct expressing an influenza virus m2-nucleoprotein fusion protein exacerbates disease after challenge with influenza a virus. J. Gen. Virol. 2002, 83, 1851–1859.
200. Baskin, C.R.; Bielefeldt-Ohmann, H.; Garcia-Sastre, A.; Tumpey, T.M.; Van Hoeven, N.; Carter, V.S.; Thomas, M.J.; Proll, S.; Solorzano, A.; Billharz, R., et al. Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an ns1-truncated influenza virus. J. Virol. 2007, 81, 11817–11827.
201. Rimmelzwaan, G.F.; Baars, M.; van Beek, R.; de Lijster, P.; de Jong, J.C.; Claas, E.C.; Osterhaus, A.D. Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an iscom-based vaccine. Vaccine 1999, 17, 2512–2516.
202. Fan, S.; Gao, Y.; Shinya, K.; Li, C.K.; Li, Y.; Shi, J.; Jiang, Y.; Suo, Y.; Tong, T.; Zhong, G. et al. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog. 2009, 5, e1000409.